Cabergoline targets multiple pathways to inhibit PRL secretion and increases stromal fibrosis. - Zhang D; Hugo W; Bergsneider M; Wang MB; Kim W; Han K; Vinters HV; Heaney AP (European journal of endocrinology, 2024)